サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：原薬 (API：Active Pharmaceutical Ingredients) の世界市場：産業動向・市場規模・市場シェア・成長機会・成長予測
市場調査レポート
商品コード
788442

原薬 (API：Active Pharmaceutical Ingredients) の世界市場：産業動向・市場規模・市場シェア・成長機会・成長予測

Active Pharmaceutical Ingredients Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024
出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 151 Pages | 納期: 2～3営業日
AI翻訳ツール 提供対象
ご購入後の翻訳ツール提供について

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=129.43円
原薬 (API：Active Pharmaceutical Ingredients) の世界市場：産業動向・市場規模・市場シェア・成長機会・成長予測
出版日: 2019年02月11日
発行: IMARC Services Private Limited
ページ情報: 英文 151 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の原薬 (API：Active Pharmaceutical Ingredients) の市場を調査し、市場の定義と概要、薬剤タイプ・製造業者タイプ・合成タイプ・適応症・地域など各種区分別の動向と市場規模の推移と予測、バリューチェーン、製造プロセス、競合環境、主要企業のプロファイルなどをまとめています。

第1章 序文

第2章 調査範囲・調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 市場概要
  • 主要産業動向

第5章 世界のAPI市場

  • 市場概要
  • 市場業績
  • 市場分析・予測：薬剤タイプ別
  • 市場分析・予測：製造業者タイプ別
  • 市場分析・予測：合成タイプ別
  • 市場分析・予測：適応症別
  • 市場分析・予測：地域別
  • 市場予測
  • SWOT分析
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • 価格分析

第6章 市場分析・予測：薬剤タイプ別

  • 先発医薬品原薬
  • ジェネリック医薬品原薬

第7章 市場分析・予測：製造業者タイプ別

  • 自社製造業者
  • 社外製造業者
    • 先発医薬品
    • ジェネリック医薬品

第8章 市場分析・予測：合成タイプ別

  • 合成原薬
    • 市場分析・予測：タイプ別
      • 先発医薬品
      • ジェネリック医薬品
  • バイオテクノロジー原薬
    • タイプ別
      • 先発医薬品
      • バイオシミラー
    • 製品別
      • モノクローナル抗体
      • ワクチン
      • サイトカイン
      • 融合タンパク質
      • 治療用酵素
      • 血液因子
    • 発現系別
      • 哺乳類発現系
      • 微生物発現系
      • 酵母発現系
      • 植物発現系
      • 昆虫発現系

第9章 市場分析・予測：適応症別

  • 癌
  • 心血管疾患
  • 糖尿病
  • 中枢神経・神経系疾患
  • 内分泌系
  • その他

第10章 市場分析・予測：地域別

  • 北米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ
  • ラテンアメリカ

第11章 製造プロセス

  • 製品概要
  • 原材料要件
  • 製造プロセス
  • 主要成功因子・リスク因子

第12章 競合環境

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Pfizer, Inc.
    • Novartis International AG
    • Sanofi
    • Boehringer Ingelheim
    • Bristol-Myers Squibb
    • Teva Pharmaceutical Industries Ltd.
    • ELI Lilly and Company
    • GlaxoSmithKline
    • Merck & Co., Inc.
    • Abbvie Inc.
図表

List of Figures

  • Figure 1: Global: Active Pharmaceutical Ingredients Market: Major Drivers and Challenges
  • Figure 2: Global: Active Pharmaceutical Ingredients Market: Sales Value (in Billion US$), 2013-2018
  • Figure 3: Global: Active Pharmaceutical Ingredients Market: Breakup by Drug Type (in %), 2018
  • Figure 4: Global: Active Pharmaceutical Ingredients Market: Breakup by Type of Manufacturer (in %), 2018
  • Figure 5: Global: Active Pharmaceutical Ingredients Market: Breakup by Type of Synthesis (in %), 2018
  • Figure 6: Global: Active Pharmaceutical Ingredients Market: Breakup by Therapeutic Application (in %), 2018
  • Figure 7: Global: Active Pharmaceutical Ingredients Market: Breakup by Region (in %), 2018
  • Figure 8: Global: Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 9: Global: Active Pharmaceutical Ingredients Industry: SWOT Analysis
  • Figure 10: Global: Active Pharmaceutical Ingredients Industry: Value Chain Analysis
  • Figure 11: Global: Active Pharmaceutical Ingredients Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Active Pharmaceutical Ingredients (Innovative Active Pharmaceutical Ingredients) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 13: Global: Active Pharmaceutical Ingredients (Innovative Active Pharmaceutical Ingredients) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 14: Global: Active Pharmaceutical Ingredients (Generic Active Pharmaceutical Ingredients) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 15: Global: Active Pharmaceutical Ingredients (Generic Active Pharmaceutical Ingredients) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 16: Global: Active Pharmaceutical Ingredients (Captive Manufacturers) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 17: Global: Active Pharmaceutical Ingredients (Captive Manufacturers) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 18: Global: Merchant API Manufacturers Market: Sales Value (in Billion US$), 2013-2018
  • Figure 19: Global: Merchant API Manufacturers Market: Breakup by Type (in %), 2018
  • Figure 20: Global: Merchant API Manufacturers (Innovative Merchant API Manufacturers) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 21: Global: Merchant API Manufacturers (Innovative Merchant API Manufacturers) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 22: Global: Merchant API Manufacturers (Generic Merchant API Manufacturers) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 23: Global: Merchant API Manufacturers (Generic Merchant API Manufacturers) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 24: Global: Merchant API Manufacturers Market: Breakup by by Synthesis (in %), 2018
  • Figure 25: Global: Merchant API Manufacturers (Synthetic APIs) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 26: Global: Merchant API Manufacturers (Synthetic APIs) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 27: Global: Merchant API Manufacturers (Biotech APIs) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 28: Global: Merchant API Manufacturers (Biotech APIs) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 29: Global: Merchant API Manufacturers Market Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 30: Global: Synthetic Active Pharmaceutical Ingredients Market: Sales Value (in Billion US$), 2013-2018
  • Figure 31: Global: Synthetic Active Pharmaceutical Ingredients Market: Breakup by Type (in %), 2018
  • Figure 32: Global: Synthetic Active Pharmaceutical Ingredients (Innovative Synthetic APIs) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 33: Global: Synthetic Active Pharmaceutical Ingredients (Innovative Synthetic APIs) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 34: Global: Synthetic Active Pharmaceutical Ingredients (Generic Synthetic APIs) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 35: Global: Synthetic Active Pharmaceutical Ingredients (Generic Synthetic APIs) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 36: Global: Synthetic Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 37: Global: Biotech Active Pharmaceutical Ingredients Market: Sales Value (in Billion US$), 2013-2018
  • Figure 38: Global: Biotech Active Pharmaceutical Ingredients Market: Breakup by Type (in %), 2018
  • Figure 39: Global: Biotech Active Pharmaceutical Ingredients (Innovative Biotech APIs) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 40: Global: Biotech Active Pharmaceutical Ingredients (Innovative Biotech APIs) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 41: Global: Biotech Active Pharmaceutical Ingredients (Biosimilars) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 42: Global: Biotech Active Pharmaceutical Ingredients (Biosimilars) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 43: Global: Biotech Active Pharmaceutical Ingredients Market: Breakup by Product (in %), 2018
  • Figure 44: Global: Biotech Active Pharmaceutical Ingredients (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 45: Global: Biotech Active Pharmaceutical Ingredients (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 46: Global: Biotech Active Pharmaceutical Ingredients (Vaccines) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 47: Global: Biotech Active Pharmaceutical Ingredients (Vaccines) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 48: Global: Biotech Active Pharmaceutical Ingredients (Cytokines) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 49: Global: Biotech Active Pharmaceutical Ingredients (Cytokines) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 50: Global: Biotech Active Pharmaceutical Ingredients (Fusion Proteins) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 51: Global: Biotech Active Pharmaceutical Ingredients (Fusion Proteins) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 52: Global: Biotech Active Pharmaceutical Ingredients (Therapeutic Enzymes) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 53: Global: Biotech Active Pharmaceutical Ingredients (Therapeutic Enzymes) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 54: Global: Biotech Active Pharmaceutical Ingredients (Blood Factors) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 55: Global: Biotech Active Pharmaceutical Ingredients (Blood Factors) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 56: Global: Biotech Active Pharmaceutical Ingredients Market: Breakup by Expression System (in %), 2018
  • Figure 57: Global: Biotech Active Pharmaceutical Ingredients (Mammalian Expression Systems) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 58: Global: Biotech Active Pharmaceutical Ingredients (Mammalian Expression Systems) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 59: Global: Biotech Active Pharmaceutical Ingredients (Microbial Expression Systems) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 60: Global: Biotech Active Pharmaceutical Ingredients (Microbial Expression Systems) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 61: Global: Biotech Active Pharmaceutical Ingredients (Yeast Expression Systems) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 62: Global: Biotech Active Pharmaceutical Ingredients (Yeast Expression Systems) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 63: Global: Biotech Active Pharmaceutical Ingredients (Plant Expression Systems) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 64: Global: Biotech Active Pharmaceutical Ingredients (Plant Expression Systems) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 65: Global: Biotech Active Pharmaceutical Ingredients (Insect Expression Systems) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 66: Global: Biotech Active Pharmaceutical Ingredients (Insect Expression Systems) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 67: Global: Biotech Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 68: Global: Active Pharmaceutical Ingredients (Oncology) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 69: Global: Active Pharmaceutical Ingredients (Oncology) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 70: Global: Active Pharmaceutical Ingredients (Cardiovascular Disease) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 71: Global: Active Pharmaceutical Ingredients (Cardiovascular Disease) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 72: Global: Active Pharmaceutical Ingredients (Diabetes) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 73: Global: Active Pharmaceutical Ingredients (Diabetes) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 74: Global: Active Pharmaceutical Ingredients (Central Nervous System and Neurological Disorders) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 75: Global: Active Pharmaceutical Ingredients (Central Nervous System and Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 76: Global: Active Pharmaceutical Ingredients (Endocrinology) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 77: Global: Active Pharmaceutical Ingredients (Endocrinology) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 78: Global: Active Pharmaceutical Ingredients (Other Applications) Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 79: Global: Active Pharmaceutical Ingredients (Other Applications) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 80: North America: Active Pharmaceutical Ingredients Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 81: North America: Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 82: Europe: Active Pharmaceutical Ingredients Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 83: Europe: Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 84: Asia Pacific: Active Pharmaceutical Ingredients Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 85: Asia Pacific: Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 86: Middle East and Africa: Active Pharmaceutical Ingredients Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 87: Middle East and Africa: Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 88: Latin America: Active Pharmaceutical Ingredients Market: Sales Value (in Million US$), 2013 & 2018
  • Figure 89: Latin America: Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 90: Active Pharmaceutical Ingredients Manufacturing: Process Flow

List of Tables

  • Table 1: Global: Active Pharmaceutical Ingredients Market: Key Industry Highlights, 2018 and 2024
  • Table 2: Global: Active Pharmaceutical Ingredients Market Forecast: Breakup by Drug (in Million US$), 2019-2024
  • Table 3: Global: Active Pharmaceutical Ingredients Market Forecast: Breakup by Type of Manufacturer (in Million US$), 2019-2024
  • Table 4: Global: Active Pharmaceutical Ingredients Market Forecast: Breakup by Type of Synthesis (in Million US$), 2019-2024
  • Table 5: Global: Active Pharmaceutical Ingredients Market Forecast: Breakup by Therapeutic Application (in Million US$), 2019-2024
  • Table 6: Global: Active Pharmaceutical Ingredients Market Forecast: Breakup by Region (in Million US$), 2019-2024
  • Table 7: Active Pharmaceutical Ingredients: Raw Material Requirements
  • Table 8: Global: Active Pharmaceutical Ingredients Market Structure
  • Table 9: Global: Active Pharmaceutical Ingredients Market: Key Players
目次
Product Code: SR1018H21_Report

The global active pharmaceutical ingredients market was worth US$ 176.3 Billion in 2018. Active pharmaceutical ingredient (API), is the term that is used to refer to the biologically active component of a drug (e.g. tablet, capsule). A drug is usually composed of several components. The API represents the primary ingredient. Other ingredients are commonly known as "excipients. Sometimes a drug can contain several APIs and its effect on a patient depends on the dosage prescribed and can vary from person to person. In combination therapies, two or more than two active ingredients are used to treat different symptoms in different ways. Stringent quality control is a mandate when it comes to the manufacturing of drugs as the API represents the main component considered while making the prescription.

Pharmaceutical manufacturing occurs in two general steps. In the first step, manufacturers convert raw materials into APIs. The second step involves creating the final formulation by mixing APIs and excipients into tablets, capsules, solutions, etc. and finally packaging the drug for the end users. Manufacturers either sell APIs in the open market (also known as the merchant market) or use them as inputs to make their final formulations. The global API market is extremely competitive with a number of large and small manufacturers. Firms that engage in API manufacturing generally specialize and target their manufacturing based on a combination of the firms in-house skills and market opportunities. Catalyzed by lower costs, API manufacturing has gradually been shifting from the historical leaders in Western countries to manufacturers based in India and China.

The global demand of APIs is currently exhibiting strong growth. One of the major drivers of this market is the rising number of blockbuster patent expiries creating a significant opportunity for generic APIs. Moreover, there has been a strong demand for APIs for biologicals. The global market for biologicals is currently exhibiting strong growth catalyzed by their high potency and ability to treat diseases beyond the scope of small molecule drugs. This is creating a strong demand for APIs for branded biological drugs and their biosimilar versions. Other factors catalyzing the global demand of APIs include ageing population, rising expenditures on healthcare, increasing prevalence of lifestyle diseases, etc. Looking forward, the market value is projected to reach US$ 247.2 Billion by 2024, exhibiting a CAGR of 5.8% during 2019-2024.

Market Summary:

Based on the drug type, the market has been segmented as innovative active pharmaceutical ingredients and generic active pharmaceutical ingredients.

Based on the type of manufacturer, the market has been segmented as captive manufacturers and merchant API manufacturers.

Based on the type of synthesis, the market has been segmented as synthetic active pharmaceutical ingredients and biotech active pharmaceutical ingredients.

Based on the therapeutic application, the market has been segmented as oncology, cardiovascular disease, diabetes, central nervous system and neurological disorders, endocrinology and others.

Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

The competitive landscape of the market has also been examined with some of the key players being Pfizer, Inc., Novartis International AG, Sanofi, Boehringer Ingelheim, Bristol-Myers Squibb, Teva Pharmaceutical Industries Ltd., ELI Lilly and Company, GlaxoSmithKline, Merck & Co., Inc. and Abbvie Inc.

Key Questions Answered in This Report:

  • How has the global active pharmaceutical ingredients market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global active pharmaceutical ingredients industry?
  • What is the breakup of the global active pharmaceutical ingredients market on the basis of drug type?
  • What is the breakup of the global active pharmaceutical ingredients market on the basis of type of manufacturer?
  • What is the breakup of the global active pharmaceutical ingredients market on the basis of synthesis?
  • What is the breakup of the global active pharmaceutical ingredients market on the basis of therapeutic application?
  • What are the various stages in the value chain of the global active pharmaceutical ingredients market?
  • What are the key driving factors and challenges in the global active pharmaceutical ingredients market?
  • What is the structure of the global active pharmaceutical ingredients market and who are the key players?
  • What is the degree of competition in the global active pharmaceutical ingredients market?
  • How are active pharmaceutical ingredients manufactured?

Table of Contents

1. Preface

2. Scope and Methodology

  • 2.1. Objectives of the Study
  • 2.2. Stakeholders
  • 2.3. Data Sources
    • 2.3.1. Primary Sources
    • 2.3.2. Secondary Sources
  • 2.4. Market Estimation
    • 2.4.1. Bottom-Up Approach
    • 2.4.2. Top-Down Approach
  • 2.5. Forecasting Methodology

3. Executive Summary

4. Introduction

  • 4.1. Overview
  • 4.2. Key Industry Trends

5. Global Active Pharmaceutical Ingredients Market

  • 5.1. Market Overview
  • 5.2. Market Performance
  • 5.3. Market Breakup by Drug Type
  • 5.4. Market Breakup by Type of Manufacturer
  • 5.5. Market Breakup by Type of Synthesis
  • 5.6. Market Breakup by Therapeutic Application
  • 5.7. Market Breakup by Region
  • 5.8. Market Forecast
  • 5.9. SWOT Analysis
    • 5.9.1. Overview
    • 5.9.2. Strengths
    • 5.9.3. Weaknesses
    • 5.9.4. Opportunities
    • 5.9.5. Threats
  • 5.10. Value Chain Analysis
  • 5.11. Porters Five Forces Analysis
    • 5.11.1. Overview
    • 5.11.2. Bargaining Power of Buyers
    • 5.11.3. Bargaining Power of Suppliers
    • 5.11.4. Degree of Competition
    • 5.11.5. Threat of New Entrants
    • 5.11.6. Threat of Substitutes
  • 5.12. Price Analysis
    • 5.12.1. Price Indicators
    • 5.12.2. Price Structure
    • 5.12.3. Margin Analysis

6. Market Breakup by Drug Type

  • 6.1. Innovative Active Pharmaceutical Ingredients
  • 6.2. Generic Active Pharmaceutical Ingredients

7. Market Breakup by Type of Manufacturer

  • 7.1. Captive Manufacturers
  • 7.2. Merchant API Manufacturers
    • 7.2.1. Innovative Merchant API Manufacturers
    • 7.2.2. Generic Merchant API Manufacturers

8. Market Breakup by Type of Synthesis

  • 8.1. Synthetic Active Pharmaceutical Ingredients
    • 8.1.1. . Market Breakup by Type
      • 8.1.1.1 Innovative Synthetic APIs
      • 8.1.1.2 Generic Synthetic APIs
  • 8.2. Biotech Active Pharmaceutical Ingredients
    • 8.2.1. . Market Breakup by Type
      • 8.2.1.1 Innovative Biotech APIs
      • 8.2.1.2 Biosimilars
    • 8.2.2. . Market Breakup By Product
      • 8.2.2.1 Monoclonal Antibodies
      • 8.2.2.2 Vaccines
      • 8.2.2.3 Cytokines
      • 8.2.2.4 Fusion Proteins
      • 8.2.2.5 Therapeutic Enzymes
      • 8.2.2.6 Blood Factors
    • 8.2.3. Market Breakup By Expression System
      • 8.2.3.1 Mammalian Expression Systems
      • 8.2.3.2 Microbial Expression Systems
      • 8.2.3.3 Yeast Expression Systems
      • 8.2.3.4 Plant Expression Systems
      • 8.2.3.5 Insect Expression Systems

9. Market Breakup by Therapeutic Application

  • 9.1. Oncology
  • 9.2. Cardiovascular Disease
  • 9.3. Diabetes
  • 9.4. Central Nervous System and Neurological Disorders
  • 9.5. Endocrinology
  • 9.6. Others

10 Market Breakup by Region

  • 10.1. North America
  • 10.2. Europe
  • 10.3. Asia Pacific
  • 10.4. Middle East and Africa
  • 10.5. Latin America

11 Manufacturing Process

  • 11.1. Product Overview
  • 11.2. Raw Material Requirements
  • 11.3. Manufacturing Process
  • 11.4. Key Success and Risk Factors

12 Competitive Landscape

  • 12.1. Market Structure
  • 12.2. Key Players
  • 12.3. Profiles of Key Players
    • 12.3.1. Pfizer, Inc.
    • 12.3.2. Novartis International AG
    • 12.3.3. Sanofi
    • 12.3.4. Boehringer Ingelheim
    • 12.3.5. Bristol-Myers Squibb
    • 12.3.6. Teva Pharmaceutical Industries Ltd.
    • 12.3.7. ELI Lilly and Company
    • 12.3.8. GlaxoSmithKline
    • 12.3.9. Merck & Co., Inc.
    • 12.3.10. Abbvie Inc.